Skip to main content

Joint Pain Injection Market Emerging Trends and Competitive Landscape Forecast To 2027 Sanofi-aventis U.S. LLC, a Sanofi Company, Pnika Therapeutics, Inc., Chugai Pharmaceutical Co., Ltd, Ferring B.V

Press release   •   Apr 17, 2019 22:10 IST

Joint Pain Injection Market

The joint pain injection market is anticipated to grow in the forecast, owing to increasing prevalence of the osteoporosis, rise in the elderly population, increasing prevalence of the rheumatoid arthritis and others. The advancement in the field of pharmaceutical and orthobiologics are likely to create growth opportunities for the joint pain injection market.

Joint pain injections are medicinal fluids inserted in the body of patients to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.


The "Global Joint Pain Injection Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical with a special focus on the global market trend analysis. The report aims to provide an overview of joint pain injection market with detailed market segmentation by injection, joint type, distribution channel and geography. The global joint pain injection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Joint pain injection market players and offers key trends and opportunities in the market.

The List of Companies:

1. Sanofi-aventis U.S. LLC, a Sanofi Company
2. Pfizer Inc
3. Anika Therapeutics, Inc.
4. Chugai Pharmaceutical Co., Ltd
5. Ferring B.V
6. Bioventus
7. Fidia Pharma USA, Inc
8. Zimmer Biomet Holdings, Inc.
9. Flexion Therapeutics, Inc
10. Seikagaku Corporation


The global joint pain injection market is segmented on the basis of injection, joint type and distribution channel. Based on the injection segment the market is classified as hyaluronic acid injections, corticosteroid injections and others. On the basis of joint type the market is segmented as knee, foot and ankle, shoulder and elbow, hip and others. Based on distribution channel the market is classified as retail pharmacies, hospitals pharmacies and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Joint pain injection market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The joint pain injection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.


The report analyzes factors affecting joint pain injection market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the joint pain injection market in these regions.

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.